SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-327160
Filing Date
2021-11-12
Accepted
2021-11-12 06:16:55
Documents
13
Period of Report
2021-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d210148d8k.htm   iXBRL 8-K 23761
2 EX-99.1 d210148dex991.htm EX-99.1 63382
  Complete submission text file 0001193125-21-327160.txt   221307

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vinc-20211112.xsd EX-101.SCH 2877
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vinc-20211112_lab.xml EX-101.LAB 18888
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vinc-20211112_pre.xml EX-101.PRE 11850
6 EXTRACTED XBRL INSTANCE DOCUMENT d210148d8k_htm.xml XML 3474
Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Filer) CIK: 0001796129 (see all company filings)

IRS No.: 833197402 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39244 | Film No.: 211399101
SIC: 2834 Pharmaceutical Preparations